Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$1.60M
8 trades · 3 insiders
Net · 90d
$-1.60M
Insiders on file
47
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Liddy Anne M. | Chief Legal Officer | 2 | $0 | $0 | 2026-09-15 |
| Bianchi Francesco | Director | 53 | $0 | $1.41M | 2026-09-10 |
| Story Brooke | Director | 20 | $0 | $388.0K | 2026-09-04 |
| Tezel Ahmet | Chief Innovation Officer | 33 | $0 | $415.9K | 2026-08-11 |
| Nygaard-Andersen Jette | Director | 1 | $0 | $0 | 2026-06-15 |
| Barry James Christopher | Director | 13 | $0 | $0 | 2026-06-15 |
| PODLOGAR SUSAN M | Director | 9 | $0 | $0 | 2026-06-15 |
| Zurbay Donald | Director | 5 | $0 | $0 | 2026-06-15 |
| Enxing Seng Stacy | Director | 29 | $0 | $0 | 2026-06-15 |
| WILVER PETER M | Director | 17 | $0 | $0 | 2026-06-15 |
| KOZY WILLIAM A | Director | 46 | $163.2K | $0 | 2026-06-15 |
| SCHERMERHORN TODD C | Director | 24 | $0 | $0 | 2026-06-15 |
| Kozmina Natalia | Chief Human Resources Officer | 14 | $0 | $0 | 2026-03-30 |
| Poletti Franco | President, Cardiopulmonary | 35 | $0 | $0 | 2026-03-30 |
| Makatsaria Vladimir | Chief Executive Officer | 25 | $0 | $0 | 2026-03-30 |
| Bolton Stephanie | President, Global Epilepsy | 41 | $0 | $0 | 2026-03-30 |
| Shvartsburg Alex | Interim CFO | 122 | $0 | $0 | 2026-03-30 |
| Hutchinson Michael Damon | SVP, CLO and Company Secretary | 32 | $0 | $0 | 2025-12-15 |
| O'Kane Sharon | Director | 41 | $58.6K | $0 | 2025-06-15 |
| Moore Daniel Jeffrey | Director | 85 | $0 | $8.12M | 2024-06-03 |
| Hebbelinck Trui | Chief Human Resources Officer | 87 | $0 | $0 | 2024-03-30 |
| Saia Andrea Lynn | Director | 33 | $0 | $0 | 2023-12-31 |
| Dolci Marco | SVP Global Operations, R&D | 92 | $0 | $686.4K | 2023-03-30 |
| McDonald Damien | CEO | 143 | $0 | $3.87M | 2023-03-30 |
| Skeffington Keyna Pidcock | General Counsel | 99 | $0 | $0 | 2022-09-15 |
| ROSENTHAL ARTHUR L | Director | 27 | $0 | $0 | 2022-06-15 |
| Novak Alfred J | Director | 37 | $46.7K | $1.03M | 2022-06-15 |
| MORRISON HUGH M | Director | 28 | $0 | $726.2K | 2021-06-29 |
| Khoury Roy | President, International | 29 | $0 | $0 | 2021-03-01 |
| Huston Thad Allen | Chief Financial Officer | 53 | $0 | $313.0K | 2020-05-23 |
| Manko Douglas John | Chief Accounting Officer | 49 | $0 | $250.3K | 2020-03-30 |
| Andrle Edward | SR VP Strategy & Bus Dev | 29 | $0 | $0 | 2019-10-18 |
| Simpson Alistair | General Manager, CS | 14 | $0 | $40.5K | 2019-05-05 |
| WISE DAVID S | SR VP HR & IT | 33 | $0 | $1.69M | 2019-01-15 |
| Gianotti Stefano | Director | 11 | $0 | $0 | 2018-03-23 |
| Sehgal Vivid | CFO | 4 | $0 | $0 | 2017-03-11 |
| BALLESTER ANDRE MICHEL | CEO | 15 | $0 | $0 | 2016-12-31 |
| EQUINOX TWO S.C.A. | 10% Owner | 9 | $0 | $28.48M | 2016-09-22 |
| Tower 6 S. a r.l. | 10% Owner | 9 | $0 | $25.28M | 2016-09-21 |
| Gutedel Jacques | President Intercontinental | 3 | $0 | $242.1K | 2016-08-09 |
| Richey Robert Jason | President, Neuromodulation | 1 | $0 | $0 | 2016-03-11 |
| Vecchi Piero | VP & Controller | 5 | $0 | $0 | 2016-03-11 |
| Sheridan Brian | SR VP Genl Counsel & Secretary | 4 | $0 | $0 | 2016-03-11 |
| Shinmar Pritpal | SR VP Global Market Access | 4 | $0 | $0 | 2016-03-11 |
| Di Lullo Stefano | Pres Cardiac Rhythm Mgmt | 1 | $0 | $0 | 2016-02-26 |
| Darnaud Michel | President Cardiac Surgery | 1 | $0 | $0 | 2016-02-26 |
| Mauro Demetrio | Chief Integration Officer | 3 | $0 | $0 | 2015-12-31 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Liddy Anne M. | Chief Legal Officer | A Award deriv | 2026-09-15 | 2026-09-16 | 6,291 | — | $0 | 6,291 | SEC↗ |
| Liddy Anne M. | Chief Legal Officer | A Award deriv | 2026-09-15 | 2026-09-16 | 6,291 | — | $0 | 6,291 | SEC↗ |
| Bianchi Francesco | Director | S Sale | 2026-09-10 | 2026-09-14 | 3,500 | $78.01 | $273.0K | 4,434 | SEC↗ |
| Bianchi Francesco | Director | S Sale | 2026-09-10 | 2026-09-14 | 3,500 | $78.01 | $273.0K | 4,434 | SEC↗ |
| Story Brooke | Director | S Sale | 2026-09-04 | 2026-09-08 | 2,300 | $81.42 | $187.3K | 7,488 | SEC↗ |
| Story Brooke | Director | S Sale | 2026-09-04 | 2026-09-08 | 2,300 | $81.42 | $187.3K | 7,488 | SEC↗ |
| Bianchi Francesco | Director | S Sale | 2026-08-31 | 2026-09-02 | 1,650 | $79.72 | $131.5K | 7,934 | SEC↗ |
| Bianchi Francesco | Director | S Sale | 2026-08-31 | 2026-09-02 | 1,650 | $79.72 | $131.5K | 7,934 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | M Exercise deriv | 2026-08-11 | 2026-08-13 | 12,692 | — | $0 | 12,691 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | M Exercise | 2026-08-11 | 2026-08-13 | 12,692 | $52.68 | $668.6K | 18,782 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | S Sale | 2026-08-11 | 2026-08-13 | 2,675 | $77.74 | $208.0K | 6,090 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | D To issuer | 2026-08-11 | 2026-08-13 | 8,589 | $77.86 | $668.7K | 10,193 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | F Tax w/h | 2026-08-11 | 2026-08-13 | 1,428 | $77.86 | $111.2K | 8,765 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | M Exercise deriv | 2026-08-11 | 2026-08-13 | 12,692 | — | $0 | 12,691 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | S Sale | 2026-08-11 | 2026-08-13 | 2,675 | $77.74 | $207.9K | 6,090 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | F Tax w/h | 2026-08-11 | 2026-08-13 | 1,428 | $77.86 | $111.2K | 8,765 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | D To issuer | 2026-08-11 | 2026-08-13 | 8,589 | $77.86 | $668.7K | 10,193 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | M Exercise | 2026-08-11 | 2026-08-13 | 12,692 | $52.68 | $668.6K | 18,782 | SEC↗ |
| Zurbay Donald | Director | A Award deriv | 2026-06-15 | 2026-06-17 | 2,383 | — | $0 | 2,383 | SEC↗ |
| Zurbay Donald | Director | M Exercise deriv | 2026-06-15 | 2026-06-17 | 2,560 | — | $0 | 0 | SEC↗ |
| Story Brooke | Director | A Award deriv | 2026-06-15 | 2026-06-17 | 2,383 | — | $0 | 2,383 | SEC↗ |
| Story Brooke | Director | M Exercise deriv | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | M Exercise deriv | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | A Award deriv | 2026-06-15 | 2026-06-17 | 2,383 | — | $0 | 2,383 | SEC↗ |
| KOZY WILLIAM A | Director | A Award deriv | 2026-06-15 | 2026-06-17 | 2,383 | — | $0 | 2,383 | SEC↗ |
| KOZY WILLIAM A | Director | M Exercise deriv | 2026-06-15 | 2026-06-17 | 5,681 | — | $0 | 0 | SEC↗ |
| Nygaard-Andersen Jette | Director | A Award deriv | 2026-06-15 | 2026-06-17 | 2,383 | — | $0 | 2,383 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | M Exercise deriv | 2026-06-15 | 2026-06-17 | 2,965 | — | $0 | 5,931 | SEC↗ |
| Barry James Christopher | Director | M Exercise deriv | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 0 | SEC↗ |
| Barry James Christopher | Director | A Award deriv | 2026-06-15 | 2026-06-17 | 2,383 | — | $0 | 2,383 | SEC↗ |
| PODLOGAR SUSAN M | Director | M Exercise deriv | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 0 | SEC↗ |
| PODLOGAR SUSAN M | Director | A Award deriv | 2026-06-15 | 2026-06-17 | 2,383 | — | $0 | 2,383 | SEC↗ |
| Bianchi Francesco | Director | M Exercise deriv | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 0 | SEC↗ |
| Bianchi Francesco | Director | A Award deriv | 2026-06-15 | 2026-06-17 | 2,383 | — | $0 | 2,383 | SEC↗ |
| SCHERMERHORN TODD C | Director | M Exercise deriv | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 0 | SEC↗ |
| SCHERMERHORN TODD C | Director | A Award deriv | 2026-06-15 | 2026-06-17 | 2,383 | — | $0 | 2,383 | SEC↗ |
| WILVER PETER M | Director | A Award deriv | 2026-06-15 | 2026-06-17 | 2,383 | — | $0 | 2,383 | SEC↗ |
| WILVER PETER M | Director | M Exercise deriv | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 0 | SEC↗ |
| Zurbay Donald | Director | M Exercise | 2026-06-15 | 2026-06-17 | 2,560 | — | $0 | 2,560 | SEC↗ |
| Zurbay Donald | Director | F Tax w/h | 2026-06-15 | 2026-06-17 | 308 | $79.70 | $24.5K | 2,252 | SEC↗ |
| Story Brooke | Director | M Exercise | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 10,274 | SEC↗ |
| Story Brooke | Director | F Tax w/h | 2026-06-15 | 2026-06-17 | 486 | $79.70 | $38.7K | 9,788 | SEC↗ |
| Enxing Seng Stacy | Director | M Exercise | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 15,793 | SEC↗ |
| Enxing Seng Stacy | Director | F Tax w/h | 2026-06-15 | 2026-06-17 | 486 | $79.70 | $38.7K | 15,307 | SEC↗ |
| KOZY WILLIAM A | Director | M Exercise | 2026-06-15 | 2026-06-17 | 5,681 | — | $0 | 38,248 | SEC↗ |
| KOZY WILLIAM A | Director | F Tax w/h | 2026-06-15 | 2026-06-17 | 682 | $79.70 | $54.4K | 37,566 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | F Tax w/h | 2026-06-15 | 2026-06-17 | 1,032 | $79.70 | $82.3K | 6,090 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | M Exercise | 2026-06-15 | 2026-06-17 | 2,965 | — | $0 | 7,122 | SEC↗ |
| Barry James Christopher | Director | M Exercise | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 8,404 | SEC↗ |
| Barry James Christopher | Director | F Tax w/h | 2026-06-15 | 2026-06-17 | 486 | $79.70 | $38.7K | 7,918 | SEC↗ |
| PODLOGAR SUSAN M | Director | M Exercise | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 6,128 | SEC↗ |
| PODLOGAR SUSAN M | Director | F Tax w/h | 2026-06-15 | 2026-06-17 | 486 | $79.70 | $38.7K | 5,642 | SEC↗ |
| Bianchi Francesco | Director | S Sale | 2026-06-15 | 2026-06-17 | 1,200 | $80.19 | $96.2K | 9,584 | SEC↗ |
| Bianchi Francesco | Director | M Exercise | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 11,270 | SEC↗ |
| Bianchi Francesco | Director | F Tax w/h | 2026-06-15 | 2026-06-17 | 486 | $79.70 | $38.7K | 10,784 | SEC↗ |
| SCHERMERHORN TODD C | Director | M Exercise | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 13,105 | SEC↗ |
| SCHERMERHORN TODD C | Director | F Tax w/h | 2026-06-15 | 2026-06-17 | 486 | $79.70 | $38.7K | 12,619 | SEC↗ |
| WILVER PETER M | Director | M Exercise | 2026-06-15 | 2026-06-17 | 4,042 | — | $0 | 10,780 | SEC↗ |
| WILVER PETER M | Director | F Tax w/h | 2026-06-15 | 2026-06-17 | 486 | $79.70 | $38.7K | 10,294 | SEC↗ |
| Bianchi Francesco | Director | S Sale | 2026-05-26 | 2026-05-27 | 1,800 | $75.75 | $136.3K | 7,228 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | M Exercise deriv | 2026-03-30 | 2026-04-01 | 2,130 | — | $0 | 4,258 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | A Award deriv | 2026-03-30 | 2026-04-01 | 3,264 | — | $0 | 3,264 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | A Award deriv | 2026-03-30 | 2026-04-01 | 9,792 | — | $0 | 9,792 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | A Award deriv | 2026-03-30 | 2026-04-01 | 3,264 | — | $0 | 3,264 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | A Award deriv | 2026-03-30 | 2026-04-01 | 3,264 | — | $0 | 3,264 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | M Exercise deriv | 2026-03-30 | 2026-04-01 | 4,259 | — | $0 | 8,518 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2026-03-30 | 2026-04-01 | 3,243 | — | $0 | 0 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2026-03-30 | 2026-04-01 | 457 | — | $0 | 0 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2026-03-30 | 2026-04-01 | 1,330 | — | $0 | 1,329 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2026-03-30 | 2026-04-01 | 1,229 | — | $0 | 2,457 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2026-03-30 | 2026-04-01 | 2,343 | — | $0 | 4,684 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | A Award deriv | 2026-03-30 | 2026-04-01 | 2,992 | — | $0 | 2,992 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2026-03-30 | 2026-04-01 | 3,156 | — | $0 | 0 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2026-03-30 | 2026-04-01 | 6,057 | — | $0 | 0 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | A Award deriv | 2026-03-30 | 2026-04-01 | 8,976 | — | $0 | 8,976 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | A Award deriv | 2026-03-30 | 2026-04-01 | 2,992 | — | $0 | 2,992 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | A Award deriv | 2026-03-30 | 2026-04-01 | 2,992 | — | $0 | 2,992 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | M Exercise deriv | 2026-03-30 | 2026-04-01 | 5,977 | — | $0 | 11,954 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | M Exercise deriv | 2026-03-30 | 2026-04-01 | 3,352 | — | $0 | 6,703 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | M Exercise deriv | 2026-03-30 | 2026-04-01 | 11,713 | — | $0 | 23,426 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 52,227 | — | $0 | 52,227 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 17,409 | — | $0 | 17,409 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 17,409 | — | $0 | 17,409 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 17,409 | — | $0 | 17,409 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2026-03-30 | 2026-04-01 | 914 | — | $0 | 0 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2026-03-30 | 2026-04-01 | 2,364 | — | $0 | 2,364 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2026-03-30 | 2026-04-01 | 1,787 | — | $0 | 3,575 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 5,440 | — | $0 | 5,440 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 5,440 | — | $0 | 5,440 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 5,440 | — | $0 | 5,440 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 16,321 | — | $0 | 16,321 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2026-03-30 | 2026-04-01 | 10,769 | — | $0 | 0 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2026-03-30 | 2026-04-01 | 5,612 | — | $0 | 0 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2026-03-30 | 2026-04-01 | 5,768 | — | $0 | 0 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2026-03-30 | 2026-04-01 | 3,621 | — | $0 | 7,240 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise deriv | 2026-03-30 | 2026-04-01 | 171 | — | $0 | 0 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise deriv | 2026-03-30 | 2026-04-01 | 325 | — | $0 | 325 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise deriv | 2026-03-30 | 2026-04-01 | 558 | — | $0 | 1,117 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise deriv | 2026-03-30 | 2026-04-01 | 2,130 | — | $0 | 4,258 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | M Exercise deriv | 2026-03-30 | 2026-04-01 | 3,408 | — | $0 | 6,814 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 4,624 | — | $0 | 4,624 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 13,873 | — | $0 | 13,873 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 4,624 | — | $0 | 4,624 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 4,624 | — | $0 | 4,624 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | F Tax w/h | 2026-03-30 | 2026-04-01 | 1,374 | $61.27 | $84.2K | 5,015 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | M Exercise | 2026-03-30 | 2026-04-01 | 6,389 | — | $0 | 6,389 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise | 2026-03-30 | 2026-04-01 | 17,815 | — | $0 | 30,566 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | F Tax w/h | 2026-03-30 | 2026-04-01 | 8,377 | $61.27 | $513.3K | 22,189 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | M Exercise | 2026-03-30 | 2026-04-01 | 21,042 | — | $0 | 25,326 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | F Tax w/h | 2026-03-30 | 2026-04-01 | 11,159 | $61.27 | $683.7K | 14,167 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | F Tax w/h | 2026-03-30 | 2026-04-01 | 12,868 | $61.27 | $788.4K | 44,647 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise | 2026-03-30 | 2026-04-01 | 30,835 | — | $0 | 57,515 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise | 2026-03-30 | 2026-04-01 | 3,184 | — | $0 | 12,125 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | F Tax w/h | 2026-03-30 | 2026-04-01 | 1,370 | $61.27 | $83.9K | 10,755 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | M Exercise | 2026-03-30 | 2026-04-01 | 3,408 | — | $0 | 5,343 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | F Tax w/h | 2026-03-30 | 2026-04-01 | 1,186 | $61.27 | $72.7K | 4,157 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise deriv | 2026-03-11 | 2026-03-13 | 2,140 | — | $0 | 0 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | F Tax w/h | 2026-03-11 | 2026-03-13 | 1,980 | $62.26 | $123.3K | 9,010 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | F Tax w/h | 2026-03-11 | 2026-03-13 | 69 | $62.26 | $4.3K | 8,941 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise | 2026-03-11 | 2026-03-13 | 2,140 | $57.60 | $123.3K | 10,990 | SEC↗ |
| Hutchinson Michael Damon | SVP, CLO and Company Secreta | M Exercise deriv | 2025-12-15 | 2025-12-17 | 2,254 | — | $0 | 2,253 | SEC↗ |
| PODLOGAR SUSAN M | Director | M Exercise deriv | 2025-12-15 | 2025-12-17 | 2,355 | — | $0 | 0 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise deriv | 2025-12-15 | 2025-12-17 | 967 | — | $0 | 0 | SEC↗ |
| Hutchinson Michael Damon | SVP, CLO and Company Secreta | M Exercise | 2025-12-15 | 2025-12-17 | 2,254 | — | $0 | 7,920 | SEC↗ |
| Hutchinson Michael Damon | SVP, CLO and Company Secreta | F Tax w/h | 2025-12-15 | 2025-12-17 | 1,122 | $63.06 | $70.8K | 6,798 | SEC↗ |
| PODLOGAR SUSAN M | Director | F Tax w/h | 2025-12-15 | 2025-12-17 | 269 | $63.06 | $17.0K | 2,086 | SEC↗ |
| PODLOGAR SUSAN M | Director | M Exercise | 2025-12-15 | 2025-12-17 | 2,355 | — | $0 | 2,355 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise | 2025-12-15 | 2025-12-17 | 967 | — | $0 | 9,266 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | F Tax w/h | 2025-12-15 | 2025-12-17 | 416 | $63.06 | $26.2K | 8,850 | SEC↗ |
| Story Brooke | Director | S Sale | 2025-11-18 | 2025-11-19 | 250 | $53.94 | $13.5K | 6,232 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise deriv | 2025-09-15 | 2025-09-17 | 643 | — | $0 | 1,932 | SEC↗ |
| Zurbay Donald | Director | A Award deriv | 2025-09-15 | 2025-09-17 | 2,560 | — | $0 | 2,560 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise | 2025-09-15 | 2025-09-17 | 643 | — | $0 | 8,576 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | F Tax w/h | 2025-09-15 | 2025-09-17 | 277 | $55.43 | $15.4K | 8,299 | SEC↗ |
| Bianchi Francesco | Director | S Sale | 2025-08-25 | 2025-08-27 | 1,500 | $56.50 | $84.8K | 9,028 | SEC↗ |
| PODLOGAR SUSAN M | Director | A Award deriv | 2025-06-15 | 2025-06-17 | 4,042 | — | $0 | 4,042 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | M Exercise deriv | 2025-06-15 | 2025-06-17 | 2,967 | — | $0 | 8,896 | SEC↗ |
| WILVER PETER M | Director | A Award deriv | 2025-06-15 | 2025-06-17 | 4,042 | — | $0 | 4,042 | SEC↗ |
| WILVER PETER M | Director | M Exercise deriv | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | A Award deriv | 2025-06-15 | 2025-06-17 | 4,042 | — | $0 | 4,042 | SEC↗ |
| Enxing Seng Stacy | Director | M Exercise deriv | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 0 | SEC↗ |
| Story Brooke | Director | A Award deriv | 2025-06-15 | 2025-06-17 | 4,042 | — | $0 | 4,042 | SEC↗ |
| Story Brooke | Director | M Exercise deriv | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 0 | SEC↗ |
| Barry James Christopher | Director | A Award deriv | 2025-06-15 | 2025-06-17 | 4,042 | — | $0 | 4,042 | SEC↗ |
| Barry James Christopher | Director | M Exercise deriv | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 0 | SEC↗ |
| KOZY WILLIAM A | Director | A Award deriv | 2025-06-15 | 2025-06-17 | 5,681 | — | $0 | 5,681 | SEC↗ |
| KOZY WILLIAM A | Director | M Exercise deriv | 2025-06-15 | 2025-06-17 | 4,840 | — | $0 | 0 | SEC↗ |
| SCHERMERHORN TODD C | Director | M Exercise deriv | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 0 | SEC↗ |
| SCHERMERHORN TODD C | Director | A Award deriv | 2025-06-15 | 2025-06-17 | 4,042 | — | $0 | 4,042 | SEC↗ |
| Bianchi Francesco | Director | A Award deriv | 2025-06-15 | 2025-06-17 | 4,042 | — | $0 | 4,042 | SEC↗ |
| Bianchi Francesco | Director | M Exercise deriv | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 0 | SEC↗ |
| O'Kane Sharon | Director | M Exercise deriv | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 0 | SEC↗ |
| O'Kane Sharon | Director | A Award deriv | 2025-06-15 | 2025-06-17 | 4,042 | — | $0 | 4,042 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | M Exercise | 2025-06-15 | 2025-06-17 | 2,967 | — | $0 | 2,967 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | F Tax w/h | 2025-06-15 | 2025-06-17 | 1,032 | $45.76 | $47.2K | 1,935 | SEC↗ |
| WILVER PETER M | Director | F Tax w/h | 2025-06-15 | 2025-06-17 | 410 | $45.76 | $18.8K | 6,738 | SEC↗ |
| WILVER PETER M | Director | M Exercise | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 7,148 | SEC↗ |
| Enxing Seng Stacy | Director | F Tax w/h | 2025-06-15 | 2025-06-17 | 410 | $45.76 | $18.8K | 11,751 | SEC↗ |
| Enxing Seng Stacy | Director | M Exercise | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 12,161 | SEC↗ |
| Story Brooke | Director | M Exercise | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 6,892 | SEC↗ |
| Story Brooke | Director | F Tax w/h | 2025-06-15 | 2025-06-17 | 410 | $45.76 | $18.8K | 6,482 | SEC↗ |
| Barry James Christopher | Director | F Tax w/h | 2025-06-15 | 2025-06-17 | 410 | $45.76 | $18.8K | 4,362 | SEC↗ |
| Barry James Christopher | Director | M Exercise | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 4,772 | SEC↗ |
| KOZY WILLIAM A | Director | F Tax w/h | 2025-06-15 | 2025-06-17 | 581 | $45.76 | $26.6K | 32,567 | SEC↗ |
| KOZY WILLIAM A | Director | M Exercise | 2025-06-15 | 2025-06-17 | 4,840 | — | $0 | 33,148 | SEC↗ |
| SCHERMERHORN TODD C | Director | M Exercise | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 9,473 | SEC↗ |
| SCHERMERHORN TODD C | Director | F Tax w/h | 2025-06-15 | 2025-06-17 | 410 | $45.76 | $18.8K | 9,063 | SEC↗ |
| Bianchi Francesco | Director | M Exercise | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 10,938 | SEC↗ |
| Bianchi Francesco | Director | F Tax w/h | 2025-06-15 | 2025-06-17 | 410 | $45.76 | $18.8K | 10,528 | SEC↗ |
| O'Kane Sharon | Director | M Exercise | 2025-06-15 | 2025-06-17 | 3,416 | — | $0 | 12,910 | SEC↗ |
| O'Kane Sharon | Director | F Tax w/h | 2025-06-15 | 2025-06-17 | 1,606 | $45.76 | $73.5K | 11,304 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise deriv | 2025-03-30 | 2025-04-01 | 172 | — | $0 | 171 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise deriv | 2025-03-30 | 2025-04-01 | 201 | — | $0 | 0 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | A Award deriv | 2025-03-30 | 2025-04-01 | 13,986 | — | $0 | 13,986 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | A Award deriv | 2025-03-30 | 2025-04-01 | 6,388 | — | $0 | 6,388 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | A Award deriv | 2025-03-30 | 2025-04-01 | 3,194 | — | $0 | 3,194 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | A Award deriv | 2025-03-30 | 2025-04-01 | 3,194 | — | $0 | 3,194 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | A Award deriv | 2025-03-30 | 2025-04-01 | 6,388 | — | $0 | 6,388 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise deriv | 2025-03-30 | 2025-04-01 | 325 | — | $0 | 650 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise deriv | 2025-03-30 | 2025-04-01 | 559 | — | $0 | 1,675 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | A Award deriv | 2025-03-30 | 2025-04-01 | 12,777 | — | $0 | 12,777 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | A Award deriv | 2025-03-30 | 2025-04-01 | 6,388 | — | $0 | 6,388 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | A Award deriv | 2025-03-30 | 2025-04-01 | 3,194 | — | $0 | 3,194 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | A Award deriv | 2025-03-30 | 2025-04-01 | 3,194 | — | $0 | 3,194 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | A Award deriv | 2025-03-30 | 2025-04-01 | 6,388 | — | $0 | 6,388 | SEC↗ |
| Kozmina Natalia | Chief Human Resources Office | A Award deriv | 2025-03-30 | 2025-04-01 | 13,986 | — | $0 | 13,986 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2025-03-30 | 2025-04-01 | 1,788 | — | $0 | 5,362 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2025-03-30 | 2025-04-01 | 2,364 | — | $0 | 4,728 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2025-03-30 | 2025-04-01 | 1,610 | — | $0 | 0 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2025-03-30 | 2025-04-01 | 1,434 | — | $0 | 0 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2025-03-30 | 2025-04-01 | 2,120 | — | $0 | 0 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 10,861 | — | $0 | 10,861 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 5,430 | — | $0 | 5,430 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 5,430 | — | $0 | 5,430 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 10,861 | — | $0 | 10,861 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2025-03-30 | 2025-04-01 | 914 | — | $0 | 914 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2025-03-30 | 2025-04-01 | 853 | — | $0 | 0 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 23,777 | — | $0 | 23,777 | SEC↗ |
| Hutchinson Michael Damon | Chief Legal Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 19,581 | — | $0 | 19,581 | SEC↗ |
| Hutchinson Michael Damon | Chief Legal Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 8,944 | — | $0 | 8,944 | SEC↗ |
| Hutchinson Michael Damon | Chief Legal Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 4,472 | — | $0 | 4,472 | SEC↗ |
| Hutchinson Michael Damon | Chief Legal Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 4,472 | — | $0 | 4,472 | SEC↗ |
| Hutchinson Michael Damon | Chief Legal Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 8,944 | — | $0 | 8,944 | SEC↗ |
| Hutchinson Michael Damon | Chief Legal Officer | M Exercise deriv | 2025-03-30 | 2025-04-01 | 1,453 | — | $0 | 4,356 | SEC↗ |
| Hutchinson Michael Damon | Chief Legal Officer | M Exercise deriv | 2025-03-30 | 2025-04-01 | 1,477 | — | $0 | 2,955 | SEC↗ |
| KOZY WILLIAM A | Director | M Exercise deriv | 2025-03-30 | 2025-04-01 | 1,034 | — | $0 | 0 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 76,927 | — | $0 | 76,927 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 35,139 | — | $0 | 35,139 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 17,569 | — | $0 | 17,569 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 17,569 | — | $0 | 17,569 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 35,139 | — | $0 | 35,139 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | M Exercise deriv | 2025-03-30 | 2025-04-01 | 5,978 | — | $0 | 17,931 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | M Exercise deriv | 2025-03-30 | 2025-04-01 | 3,352 | — | $0 | 10,055 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2025-03-30 | 2025-04-01 | 1,060 | — | $0 | 0 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2025-03-30 | 2025-04-01 | 426 | — | $0 | 0 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | A Award deriv | 2025-03-30 | 2025-04-01 | 15,385 | — | $0 | 15,385 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | A Award deriv | 2025-03-30 | 2025-04-01 | 3,513 | — | $0 | 3,513 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | A Award deriv | 2025-03-30 | 2025-04-01 | 3,513 | — | $0 | 3,513 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | A Award deriv | 2025-03-30 | 2025-04-01 | 7,027 | — | $0 | 7,027 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | A Award deriv | 2025-03-30 | 2025-04-01 | 7,027 | — | $0 | 7,027 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2025-03-30 | 2025-04-01 | 717 | — | $0 | 0 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2025-03-30 | 2025-04-01 | 805 | — | $0 | 0 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2025-03-30 | 2025-04-01 | 1,229 | — | $0 | 3,686 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2025-03-30 | 2025-04-01 | 1,330 | — | $0 | 2,659 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise deriv | 2025-03-30 | 2025-04-01 | 457 | — | $0 | 457 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 10,222 | — | $0 | 10,222 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 5,111 | — | $0 | 5,111 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 22,378 | — | $0 | 22,378 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 10,222 | — | $0 | 10,222 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2025-03-30 | 2025-04-01 | 5,111 | — | $0 | 5,111 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | F Tax w/h | 2025-03-30 | 2025-04-01 | 542 | $39.13 | $21.2K | 7,933 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise | 2025-03-30 | 2025-04-01 | 1,257 | — | $0 | 8,475 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | F Tax w/h | 2025-03-30 | 2025-04-01 | 3,516 | $39.13 | $137.6K | 26,680 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise | 2025-03-30 | 2025-04-01 | 11,083 | — | $0 | 30,196 | SEC↗ |
| Hutchinson Michael Damon | Chief Legal Officer | F Tax w/h | 2025-03-30 | 2025-04-01 | 1,020 | $39.13 | $39.9K | 5,666 | SEC↗ |
| Hutchinson Michael Damon | Chief Legal Officer | M Exercise | 2025-03-30 | 2025-04-01 | 2,930 | — | $0 | 6,686 | SEC↗ |
| KOZY WILLIAM A | Director | F Tax w/h | 2025-03-30 | 2025-04-01 | 188 | $39.13 | $7.4K | 28,308 | SEC↗ |
| KOZY WILLIAM A | Director | M Exercise | 2025-03-30 | 2025-04-01 | 1,034 | — | $0 | 28,496 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | M Exercise | 2025-03-30 | 2025-04-01 | 9,330 | — | $0 | 9,330 | SEC↗ |
| Makatsaria Vladimir | Chief Executive Officer | F Tax w/h | 2025-03-30 | 2025-04-01 | 5,046 | $39.13 | $197.4K | 4,284 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | M Exercise | 2025-03-30 | 2025-04-01 | 6,024 | — | $0 | 15,586 | SEC↗ |
| Bolton Stephanie | President, Global Epilepsy | F Tax w/h | 2025-03-30 | 2025-04-01 | 2,835 | $39.13 | $110.9K | 12,751 | SEC↗ |
| PODLOGAR SUSAN M | Director | A Award deriv | 2024-12-15 | 2024-12-17 | 2,355 | — | $0 | 2,355 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise deriv | 2024-12-15 | 2024-12-17 | 613 | — | $0 | 0 | SEC↗ |
| Barry James Christopher | Director | M Exercise deriv | 2024-12-15 | 2024-12-17 | 1,709 | — | $0 | 0 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise deriv | 2024-12-15 | 2024-12-17 | 967 | — | $0 | 967 | SEC↗ |
| Hutchinson Michael Damon | Chief Legal Officer | M Exercise deriv | 2024-12-15 | 2024-12-17 | 2,254 | — | $0 | 4,507 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | M Exercise | 2024-12-15 | 2024-12-17 | 613 | — | $0 | 19,342 | SEC↗ |
| Shvartsburg Alex | Chief Financial Officer | F Tax w/h | 2024-12-15 | 2024-12-17 | 229 | $51.50 | $11.8K | 19,113 | SEC↗ |
| Barry James Christopher | Director | F Tax w/h | 2024-12-15 | 2024-12-17 | 353 | $51.50 | $18.2K | 1,356 | SEC↗ |
| Barry James Christopher | Director | M Exercise | 2024-12-15 | 2024-12-17 | 1,709 | — | $0 | 1,709 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | M Exercise | 2024-12-15 | 2024-12-17 | 967 | — | $0 | 7,634 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | F Tax w/h | 2024-12-15 | 2024-12-17 | 416 | $51.50 | $21.4K | 7,218 | SEC↗ |
| Hutchinson Michael Damon | Chief Legal Officer | F Tax w/h | 2024-12-15 | 2024-12-17 | 784 | $51.50 | $40.4K | 3,756 | SEC↗ |
| Hutchinson Michael Damon | Chief Legal Officer | M Exercise | 2024-12-15 | 2024-12-17 | 2,254 | — | $0 | 4,540 | SEC↗ |
| Bianchi Francesco | Director | S Sale | 2024-12-11 | 2024-12-13 | 1,250 | $50.99 | $63.7K | 7,522 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | A Award deriv | 2024-09-15 | 2024-09-17 | 5,885 | — | $0 | 5,885 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | A Award deriv | 2024-09-15 | 2024-09-17 | 1,287 | — | $0 | 1,287 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | A Award deriv | 2024-09-15 | 2024-09-17 | 2,575 | — | $0 | 2,575 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | A Award deriv | 2024-09-15 | 2024-09-17 | 1,287 | — | $0 | 1,287 | SEC↗ |
| Poletti Franco | President, Cardiopulmonary | A Award deriv | 2024-09-15 | 2024-09-17 | 2,575 | — | $0 | 2,575 | SEC↗ |
| Bianchi Francesco | Director | S Sale | 2024-09-11 | 2024-09-13 | 1,500 | $46.58 | $69.9K | 8,772 | SEC↗ |
| Story Brooke | Director | M Exercise deriv | 2024-06-15 | 2024-06-18 | 2,680 | — | $0 | 0 | SEC↗ |
| Story Brooke | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 3,416 | — | $0 | 3,416 | SEC↗ |
| O'Kane Sharon | Director | M Exercise deriv | 2024-06-15 | 2024-06-18 | 2,680 | — | $0 | 0 | SEC↗ |
| O'Kane Sharon | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 3,416 | — | $0 | 3,416 | SEC↗ |
| KOZY WILLIAM A | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 4,840 | — | $0 | 4,840 | SEC↗ |
| SCHERMERHORN TODD C | Director | M Exercise deriv | 2024-06-15 | 2024-06-18 | 2,680 | — | $0 | 0 | SEC↗ |
| SCHERMERHORN TODD C | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 3,416 | — | $0 | 3,416 | SEC↗ |
| Bianchi Francesco | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 3,416 | — | $0 | 3,416 | SEC↗ |
| Bianchi Francesco | Director | M Exercise deriv | 2024-06-15 | 2024-06-18 | 2,680 | — | $0 | 0 | SEC↗ |
| Shvartsburg Alex | CFO | M Exercise deriv | 2024-06-15 | 2024-06-18 | 1,576 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | M Exercise deriv | 2024-06-15 | 2024-06-18 | 2,680 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 3,416 | — | $0 | 3,416 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2024-06-15 | 2024-06-18 | 3,559 | — | $0 | 3,559 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2024-06-15 | 2024-06-18 | 7,118 | — | $0 | 7,118 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2024-06-15 | 2024-06-18 | 25,383 | — | $0 | 25,383 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2024-06-15 | 2024-06-18 | 3,559 | — | $0 | 3,559 | SEC↗ |
| Tezel Ahmet | Chief Innovation Officer | A Award deriv | 2024-06-15 | 2024-06-18 | 11,863 | — | $0 | 11,863 | SEC↗ |
| WILVER PETER M | Director | M Exercise deriv | 2024-06-15 | 2024-06-18 | 2,680 | — | $0 | 0 | SEC↗ |
| WILVER PETER M | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 3,416 | — | $0 | 3,416 | SEC↗ |
| Barry James Christopher | Director | A Award deriv | 2024-06-15 | 2024-06-18 | 3,416 | — | $0 | 3,416 | SEC↗ |
| Story Brooke | Director | M Exercise | 2024-06-15 | 2024-06-18 | 2,680 | — | $0 | 4,060 | SEC↗ |
| Story Brooke | Director | F Tax w/h | 2024-06-15 | 2024-06-18 | 584 | $52.68 | $30.8K | 3,476 | SEC↗ |
| O'Kane Sharon | Director | M Exercise | 2024-06-15 | 2024-06-18 | 2,680 | — | $0 | 10,754 | SEC↗ |
| O'Kane Sharon | Director | F Tax w/h | 2024-06-15 | 2024-06-18 | 1,260 | $52.68 | $66.4K | 9,494 | SEC↗ |
| SCHERMERHORN TODD C | Director | M Exercise | 2024-06-15 | 2024-06-18 | 2,680 | — | $0 | 6,643 | SEC↗ |
| SCHERMERHORN TODD C | Director | F Tax w/h | 2024-06-15 | 2024-06-18 | 586 | $52.68 | $30.9K | 6,057 | SEC↗ |
| Bianchi Francesco | Director | M Exercise | 2024-06-15 | 2024-06-18 | 2,680 | — | $0 | 10,857 | SEC↗ |
| Bianchi Francesco | Director | F Tax w/h | 2024-06-15 | 2024-06-18 | 585 | $52.68 | $30.8K | 10,272 | SEC↗ |
| Shvartsburg Alex | CFO | F Tax w/h | 2024-06-15 | 2024-06-18 | 670 | $52.68 | $35.3K | 18,729 | SEC↗ |
| Shvartsburg Alex | CFO | M Exercise | 2024-06-15 | 2024-06-18 | 1,576 | — | $0 | 19,399 | SEC↗ |
| Enxing Seng Stacy | Director | F Tax w/h | 2024-06-15 | 2024-06-18 | 585 | $52.68 | $30.8K | 8,745 | SEC↗ |
| Enxing Seng Stacy | Director | M Exercise | 2024-06-15 | 2024-06-18 | 2,680 | — | $0 | 9,330 | SEC↗ |
| WILVER PETER M | Director | M Exercise | 2024-06-15 | 2024-06-18 | 2,680 | — | $0 | 4,317 | SEC↗ |
| WILVER PETER M | Director | F Tax w/h | 2024-06-15 | 2024-06-18 | 585 | $52.68 | $30.8K | 3,732 | SEC↗ |
| Moore Daniel Jeffrey | Director | M Exercise deriv | 2024-06-03 | 2024-06-05 | 56,623 | — | $0 | 0 | SEC↗ |
| Moore Daniel Jeffrey | Director | S Sale | 2024-06-03 | 2024-06-05 | 54,578 | $60.08 | $3.28M | 29,579 | SEC↗ |
| Moore Daniel Jeffrey | Director | M Exercise | 2024-06-03 | 2024-06-05 | 56,623 | $57.39 | $3.25M | 84,157 | SEC↗ |
| Moore Daniel Jeffrey | Director | S Sale | 2024-06-03 | 2024-06-05 | 2,045 | $61.09 | $124.9K | 27,534 | SEC↗ |